2 results match your criteria: "Kantonsspital Aarau and faculty at the University of Basel[Affiliation]"
Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
Curr Med Res Opin
May 2021
Medical University Department, Kantonsspital Aarau and faculty at the University of Basel, Basel, Switzerland.
Article Synopsis
- The study investigates the effectiveness of a procalcitonin-based antibiotic stewardship program in community hospitals to reduce inappropriate antibiotic use, addressing the global concern of antimicrobial resistance.
- Conducted as a matched cohort study, the research compared patients from hospitals implementing the procalcitonin protocol with those from hospitals without it, focusing on various demographic and clinical factors.
- Results indicated that patients in procalcitonin cohort hospitals received 1.47 fewer days of antibiotic therapy, though there was a noted increase in acute kidney injury, but no significant differences in length of stay or other adverse outcomes.
ProCommunity: procalcitonin use in real-world US community hospital settings.
Curr Med Res Opin
September 2020
Medical University Department, Kantonsspital Aarau and Faculty at the University of Basel, Aarau, Switzerland.
Objective: Procalcitonin (PCT) is a biomarker that may help providers optimize antibiotic (AB) therapy. Numerous clinical trials have demonstrated the utility of PCT-guided decision algorithms in treating lower respiratory tract infections and sepsis, but evidence from real-world studies is limited. This study sought to evaluate the effects of PCT on select clinical outcomes in community hospitals.
View Article and Find Full Text PDF